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Abstract
As more than 40 states face present and projected deficits in their health care budgets, some legislatures are
considering market-based reforms to control rising health care costs. This continues a trend begun in the
1990s that emphasized market competition over state regulation and mandates. However, little is known
about the impact of many market-based reforms on quality of care. This Issue Brief evaluates the effect of one
reform—the deregulation of hospital reimbursement rates in New Jersey—on one important outcome of
care—mortality from acute myocardial infarction (heart attack). The findings serve as a reminder that cost-
constraining reforms may reduce the quality of care, particularly for uninsured and other vulnerable
populations.
License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
This brief is available at ScholarlyCommons: http://repository.upenn.edu/ldi_issuebriefs/37
Leonard Davis Institute of Health Economics
LDI Issue Brief
Volume 8, Number 7
April 2003
Kevin G.M. Volpp, MD, PhD
LDI Senior Fellow,
Assistant Professor of Medicine &
Health Care Systems
University of Pennsylvania
VA HSR&D Research Associate
Sankey V. Williams, MD
LDI Senior Fellow,
Sol Katz Professor of General Internal
Medicine & Health Care Systems
University of Pennsylvania
Mark V. Pauly, PhD
LDI Senior Fellow, Bendheim Professor
of Health Care Systems
University of Pennsylvania
and colleagues (see back)
State regulation of hospital
rates virtually disappear ed
in the 1990s
Market Reform in New Jersey and Quality of
Care: A Cautionary Tale
Editor’s note: As more than 40 states face present and projected deficits in
their health care budgets, some legislatures are considering market-based
reforms to control rising health care costs.  This continues a trend begun in
the 1990s that emphasized market competition over state regulation and
mandates.  However, little is known about the impact of many market-based
reforms on quality of care.  This Issue Brief evaluates the effect of one
reform—the deregulation of hospital reimbursement rates in New Jersey—on
one important outcome of care—mortality from acute myocardial infarction
(heart attack).  The findings serve as a reminder that cost-constraining
reforms may reduce the quality of care, particularly for uninsured and other
vulnerable populations.
In the 1970s and ’80s, many states implemented regulations setting hospital
reimbursement rates for private insurers and, in some cases, for all insurers.  Hospital
rate-setting was considered a cost-containment tool that could also spread the costs
of charity care, because most rate-setting models built subsidies for uncompensated
care directly into hospital rates.
• By 1980, about 30 states had some form of hospital rate-setting.  Their provisions
differed, especially on whether all payers (including Medicare) were subject to
regulation.  States with an all-payer system (requiring federal waivers for
Medicare) were thought to have the greatest potential for cost savings, and the
greatest ability to distribute the financial burden of charity care across payers. All-
payer states included Maryland (1977), New Jersey (1978), Massachusetts (1982),
and New York (1982).
• Studies indicate that rate-setting systems were effective in controlling costs per
hospital admission, but ineffective in controlling health care costs overall.  These
systems did not control the number of hospital admissions, nor did they regulate
outpatient costs. With the rise of managed care and its broader potential to
contain health care costs, most states turned to market-based strategies and
abandoned regulatory initiatives. By 1997, only Maryland had retained its
hospital rate-setting regulation, and it remains the only state still setting hospital
rates today.
Study evaluates the effects of
market reform on heart
attack mor tality
Mortality rates increase
among uninsur ed patients in
New Jersey after reforms
• In 1992, New Jersey replaced its rate-setting system with a deregulated system
that encouraged price competition and negotiation among hospitals and payers.
It also substantially reduced subsidies for hospital care for the uninsured, which
had been financed through a 19% surcharge on all hospital bills.  As a result, state
funding for charity care decreased from $700 million in 1992 to $350 million in
1996.
To identify changes in the quality of care in New Jersey after the 1992 reforms,
Volpp and colleagues studied patients hospitalized for acute myocardial infarction
(AMI), a common high-mortality condition whose outcomes are affected by the
process of care.  To measure the effect of the change in hospital financing, the
authors compared how in-hospital mortality rates changed over time in New Jersey
relative to changes over time in New York.
• The study focused on how AMI outcomes and cardiac procedure rates changed
from the pre-reform period (1990-1992) to the post-reform period (1994-1996).
1993 was considered a transition year before full implementation of the reforms
in 1994.
• New York was chosen as a comparison state because it has a large population, it is
adjacent to New Jersey, and had no major policy changes in its hospital financing
system from 1990 to 1996.  New York eliminated its state hospital rate-setting
system in 1997.
• The authors also compared their findings with national AMI mortality data from
the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project
(HCUP).  This analysis corroborated time trends and put the results from the two
states into a national context.
The study included a total of 286,640 patient records from New York and New
Jersey, using comparable hospital discharge data from each state. The number of
admissions for AMI patients in the two states was roughly constant from year to
year.  About 6% of these patients were uninsured in New Jersey from 1992-1996
(varying slightly each year), while the percentage of uninsured patients in New York
increased slightly from 3.6% in 1992 to 4.3%-4.7% in 1994-1996.
• Mortality rates for insured patients declined steadily throughout the study period
in New York and New Jersey. The rate of decline from 1990 to 1992 was similar
in New York and New Jersey. Following the introduction of the reforms in New
Jersey in 1992, the mortality rates leveled off in New Jersey but continued to
decline in New York. However, the difference was smaller than that considered
statistically significant.
• Among uninsured patients in New York, mortality rates decreased from 12% in
1992 to 8% in 1996. In contrast, mortality rates among uninsured patients in
New Jersey increased from 7.8% in 1992 to 8.3% in 1996.
• After adjusting for many risk factors including the patient’s age, sex, and other
clinical conditions, the authors conclude that, compared to New York, there was a
relative increase in mortality of 41%-57% among uninsured patients in New
Jersey in the post-reform period.  This represents about 99 excess deaths in New
Jersey.
Continued on back.
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POLICY IMPLICA TIONS
The mechanisms by which AMI in-hospital mortality increased relative to New York
are unclear, but one contributing factor may have been differences in the use of
beneficial cardiac procedures, such as cardiac catheterization and mechanical
revascularization (heart bypass surgery or angioplasty).
• Reflecting technological improvements over time, the use of these procedures
steadily increased in both states during the study period.  However, the rate of
increase in New Jersey lagged significantly behind New York after 1992.
• This slowdown in New Jersey was observed for both insured and uninsured
patients, but was more pronounced for uninsured patients.  The catheterization
rate in New Jersey for uninsured patients was 36.4% pre-reform, and it increased
less than the rate in New York by 9.4  to 17.3 percentage points from the pre-
reform to the post-reform period.  Similarly, for uninsured patients, the
mechanical revascularization rate in New Jersey was 17.3% pre-reform, and it
increased less than the rate in New York by 4.0 to 14.1 percentage points in the
post-reform period.
• The study could not measure other factors that might have played a role in
differential AMI mortality rates, such as less frequent use of aspirin and beta
blockers, lower nurse/patient ratios, and delays in diagnosis or treatment.
The authors investigated whether the observed differences in AMI mortality could
be due to changes in New York, rather than reforms in New Jersey.
• Analysis of data from 364,273 patients in the HCUP Nationwide Inpatient
Sample revealed that national trends in AMI mortality in the study period
mirrored those of New York for both insured and uninsured patients.
• New York instituted a Cardiac Surgery Reporting System in 1989, in which
mortality rates were publicly reported for each hospital.  If this system led to
improved surgical outcomes for AMI patients who had bypass surgery in New
York, it might explain the differential mortality changes between the two states in
the study period. However, when the authors examined mortality rates for the
subset of AMI patients who had bypass surgery in each state, they found the
opposite effect—that is, from 1992-1996, mortality for heart bypass patients
increased 7.1% in New York, and decreased by 15.8% in New Jersey. Thus,
bypass mortality rates did not improve in New York for AMI patients, and cannot
explain the differences in AMI mortality rates between the two states in this study.
• The authors also ruled out other possible explanations of the results, such as
changes in the characteristics of the uninsured population in each state, changes
in the transfer rate between hospitals (since pretransfer hospitalizations were
excluded from the study), and major changes in the length of hospital stays.
Consistent with differences in cardiac procedure rates, average length of stay
decreased slightly more in New Jersey than in New York in the post-reform period,
which would bias against finding a relative increase in mortality in New Jersey.
These findings indicate that the outcomes of care for uninsured patients with AMIs
in New Jersey declined following the 1992 deregulation of hospital reimbursement
rates.  Although the authors cannot be sure about a cause and effect relationship, these
results are consistent with the hypothesis that the uninsured were particularly vulnerable
in the switch to a market-based system, which cut state subsidies for their care.
New Jersey rates of using
cardiac procedures lag
behind N ew York after
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Continued
• In New Jersey, the number of hospitalized uninsured patients with AMIs did not
change greatly over time, suggesting that access to care was maintained for
medical emergencies after reform.  However, the relative decreases in cardiac
procedure rates in New Jersey suggest that patients were managed differently once
they were admitted in the post-reform period.  This possibility warrants further
study.
• Because inpatient care for the uninsured is funded primarily from hospital
revenues in excess of costs, reforms that put increased pressure on hospital
margins are more likely to affect the quality of care provided to the uninsured.
• As state and federal policymakers consider reforms to contain rising hospital
costs—for example, changes in Medicare and Medicaid payments to providers—
they need to recognize the potential impact on quality of care. Market-based
reforms, in particular, should be coupled with explicit strategies for maintaining
funding levels for care of the uninsured and monitoring the impact of such
reforms on the quality of care for this population.
